Covington represented Elanco Animal Health in the transaction. Elanco Animal Health entered into an agreement with Dechra Pharmaceuticals to divest Osurnia® for $135 million in an…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now